An enigma: why vitamin A supplementation does not always reduce mortality even though vitamin A deficiency is associated with increased mortality
Open Access
- 1 June 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 44 (3) , 906-918
Abstract
Background: Vitamin A deficiency (VAD) is associated with increased mortality. To prevent VAD, WHO recommends high-dose vitamin A supplementation (VAS) every 4–6 months for children aged between 6 months and 5 years of age in countries at risk of VAD. The policy is based on randomized clinical trials (RCTs) conducted in the late 1980s and early 1990s. Recent RCTs indicate that the policy may have ceased to be beneficial. In addition, RCTs attempting to extend the benefits to younger children have yielded conflicting results. Stratified analyses suggest that whereas some subgroups benefit more than expected from VAS, other subgroups may experience negative effects. Methods and Results: We reviewed the potential modifiers of the effect of VAS. The variable effect of VAS was not explained by underlying differences in VAD. Rather, the effect may depend on the sex of the child, the vaccine status and previous supplementation with vitamin A. Vitamin A is known to affect the Th1/Th2 balance and, in addition, recent evidence suggests that vitamin A may also induce epigenetic changes leading to down-regulation of the innate immune response. Thus VAS protects against VAD but has also important and long-lasting immunological effects, and the effect of providing VAS may vary depending on the state of the immune system. Conclusions: To design optimal VAS programmes which target those who benefit and avoid those harmed, more studies are needed. Work is ongoing to define whether neonatal VAS should be considered in subgroups. In the most recent RCT in older children, VAS doubled the mortality for males but halved mortality for females. Hence, we urgently need to re-assess the effect of VAS on older children in large-scale RCTs powered to study effect modification by sex and other potential effect modifiers, and with nested immunological studies.Keywords
This publication has 68 references indexed in Scilit:
- Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trialThe Lancet, 2013
- Determinants of vitamin a deficiency in children between 6 months and 2 years of age in Guinea-BissauBMC Public Health, 2013
- Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytesProceedings of the National Academy of Sciences, 2012
- Testing the hypothesis that diphtheria–tetanus–pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countriesBMJ Open, 2012
- Early diphtheria-tetanus-pertussis vaccination associated with higher female mortality and no difference in male mortality in a cohort of low birthweight children: an observational study within a randomised trialArchives of Disease in Childhood, 2012
- Does the effect of vitamin A supplements depend on vaccination status? An observational study from Guinea-BissauBMJ Open, 2012
- The impact of different doses of vitamin A supplementation on male and female mortality. A randomised trial from Guinea-BissauBMC Pediatrics, 2011
- Effects of All-Trans Retinoic Acid on Th1- and Th2-Related Chemokines Production in MonocytesInflammation, 2008
- The effect of vitamin A supplementation administered with missing vaccines during national immunization days in Guinea-BissauInternational Journal of Epidemiology, 2008
- Effect of 50 000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trialBMJ, 2008